BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25605418)

  • 1. Artificial neural network in diagnosis of urothelial cell carcinoma in urine cytology.
    Muralidaran C; Dey P; Nijhawan R; Kakkar N
    Diagn Cytopathol; 2015 Jun; 43(6):443-9. PubMed ID: 25605418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural network in diagnosis of metastatic carcinoma in effusion cytology.
    Barwad A; Dey P; Susheilia S
    Cytometry B Clin Cytom; 2012 Mar; 82(2):107-11. PubMed ID: 22076948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Back propagation neural network in the discrimination of benign from malignant lower urinary tract lesions.
    Pantazopoulos D; Karakitsos P; Iokim-Liossi A; Pouliakis A; Botsoli-Stergiou E; Dimopoulos C
    J Urol; 1998 May; 159(5):1619-23. PubMed ID: 9554366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma.
    Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S
    Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial neural network in diagnosis of lobular carcinoma of breast in fine-needle aspiration cytology.
    Dey P; Logasundaram R; Joshi K
    Diagn Cytopathol; 2013 Feb; 41(2):102-6. PubMed ID: 21987420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of radial basis function neural networks in discriminating benign from malignant lesions of the lower urinary tract.
    Karakitsos P; Pouliakis A; Kordalis G; Georgoulakis J; Kittas C; Kyroudes A
    Anal Quant Cytol Histol; 2005 Feb; 27(1):35-42. PubMed ID: 15794450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
    Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial neural network in breast lesions from fine-needle aspiration cytology smear.
    Subbaiah RM; Dey P; Nijhawan R
    Diagn Cytopathol; 2014 Mar; 42(3):218-24. PubMed ID: 23908018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.
    Alameda F; Juanpere N; Pijuan L; Lloveras B; Gimeno J; Baró T; Salido M; Serrano S; Lloreta J
    Cancer Cytopathol; 2012 Aug; 120(4):276-82. PubMed ID: 22419364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of an artificial intelligence algorithm for reporting urine cytopathology.
    Sanghvi AB; Allen EZ; Callenberg KM; Pantanowitz L
    Cancer Cytopathol; 2019 Oct; 127(10):658-666. PubMed ID: 31412169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing neural networks in the discrimination of benign from malignant lower urinary tract lesions.
    Pantazopoulos D; Karakitsos P; Iokim-Liossi A; Pouliakis A; Dimopoulos K
    Br J Urol; 1998 Apr; 81(4):574-9. PubMed ID: 9598630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the "suspicious for urothelial carcinoma" cytology category: a correlative study of 4 years including 337 patients.
    Ton Nu TN; Kassouf W; Ahmadi-Kaliji B; Charbonneau M; Auger M; Brimo F
    Cancer Cytopathol; 2014 Nov; 122(11):796-803. PubMed ID: 24909774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micronucleus in atypical urothelial cells.
    Arora SK; Dey P; Saikia UN
    Diagn Cytopathol; 2010 Nov; 38(11):811-3. PubMed ID: 20049965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of atypical urine cytology progression to malignancy.
    Muus Ubago J; Mehta V; Wojcik EM; Barkan GA
    Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic classification of urothelial cells in urine cytology specimens using exclusively spectral information.
    Jaganath R; Angeletti C; Levenson R; Rimm DL
    Cancer; 2004 Jun; 102(3):186-91. PubMed ID: 15211478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
    Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
    Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.